← Leaderboards
Cyrus Vaziri
Univ Of North Carolina Chapel Hill
$12,585,722
Attributed
$16,193,949
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$16,193,949 · 9
By mechanism
R01$15,613,421 · 7
R21$359,500 · 1
R29$221,028 · 1
Top collaborators
- Kenneth Hugh Pearce11 shared
- Scott E Williams5 shared
- William Perry Janzen1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Kenneth Hugh Pearce$13,826,383
- Michael Luca Durando$155,497
- Lauren Carole Frazer$348,228
Others in their field
Top investigators on “Dna Damage”
- Robert H Vonderheide · University Of Pennsylvania$45,163,553
- F Peter Guengerich · Vanderbilt University$33,973,148
- Aziz Sancar · University Of North Carolina Chapel Hill$31,216,731
- Robert O Wright · Brigham And Women'S Hospital$30,479,869
- John A Tainer · Scripps Research Institute$27,554,249
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$27,391,656
Research focus
Dna DamagePathway InteractionsCellsCancer CellCancer TherapyMalignant NeoplasmsPreventDna BiosynthesisSignal TransductionChemotherapyResistanceBaseResponseGenomic InstabilityDna RepairUbiquitin-Protein LigaseLesionGenomeNeoplastic CellMolecularProteinsSmall MoleculeInnovationMission
Grant awards (49)
Pathological Reprogramming of DNA Damage Signaling in Neoplastic Cells$463,301
R01 · FY2023 · ES · contact PI
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target$391,466
R01 · FY2023 · CA · contact PI
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis$508,083
R01 · FY2022 · CA · contact PI
Pathological Reprogramming of DNA Damage Signaling in Neoplastic Cells$463,301
R01 · FY2022 · ES · contact PI
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target$344,451
R01 · FY2022 · CA · contact PI
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis$518,457
R01 · FY2021 · CA · contact PI
Pathological Reprogramming of DNA Damage Signaling in Neoplastic Cells$463,301
R01 · FY2021 · ES · contact PI
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target$402,605
R01 · FY2021 · CA · contact PI
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target$80,061
R01 · FY2021 · CA · contact PI
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis$518,457
R01 · FY2020 · CA · contact PI
Pathological Reprogramming of DNA Damage Signaling in Neoplastic Cells$467,927
R01 · FY2020 · ES · contact PI
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target$403,864
R01 · FY2020 · CA · contact PI
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis$502,902
R01 · FY2019 · CA · contact PI
Pathological Reprogramming of DNA Damage Signaling in Neoplastic Cells$469,870
R01 · FY2019 · ES · contact PI
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target$413,559
R01 · FY2019 · CA · contact PI
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis$518,457
R01 · FY2018 · CA · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$333,000
R01 · FY2016 · ES · contact PI
Targeting the TLS DNA Damage Tolerance Pathway for Cancer Therapy$286,392
R01 · FY2016 · GM · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$333,000
R01 · FY2015 · ES · contact PI
Targeting the TLS DNA Damage Tolerance Pathway for Cancer Therapy$286,392
R01 · FY2015 · GM · contact PI
Novel Rad18 functions in Histone Modification and Regulation of Gene Expression$157,500
R21 · FY2015 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$329,670
R01 · FY2014 · ES · contact PI
Targeting the TLS DNA Damage Tolerance Pathway for Cancer Therapy$286,392
R01 · FY2014 · GM · contact PI
Novel Rad18 functions in Histone Modification and Regulation of Gene Expression$202,000
R21 · FY2014 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$326,340
R01 · FY2013 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$333,000
R01 · FY2012 · ES · contact PI
A Novel Role for the Fanconi Anemia Pathway in Replication of B[a]P-Adducted DNA$293,736
R01 · FY2012 · ES · contact PI
A Novel Role for the Fanconi Anemia Pathway in Replication of B[a]P-Adducted DNA$293,736
R01 · FY2011 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$282,104
R01 · FY2011 · ES · contact PI
A Novel Role for the Fanconi Anemia Pathway in Replication of B[a]P-Adducted DNA$296,703
R01 · FY2010 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$284,953
R01 · FY2010 · ES · contact PI
A Novel Role for the Fanconi Anemia Pathway in Replication of B[a]P-Adducted DNA$299,700
R01 · FY2009 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$276,341
R01 · FY2009 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$12,617
R01 · FY2009 · ES · contact PI
A Novel Role for the Fanconi Anemia Pathway in Replication of B[a]P-Adducted DNA$329,063
R01 · FY2008 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$316,032
R01 · FY2008 · ES · contact PI
A Novel DNA Re-replication Checkpoint$292,199
R01 · FY2008 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$329,063
R01 · FY2007 · ES · contact PI
A Novel DNA Re-replication Checkpoint$298,162
R01 · FY2007 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$315,410
R01 · FY2006 · ES · contact PI
A Novel DNA Re-replication Checkpoint$307,067
R01 · FY2006 · ES · contact PI
A Novel Carcinogen-Induced Cell Cycle Checkpoint$323,000
R01 · FY2005 · ES
A Novel DNA Re-replication Checkpoint$314,456
R01 · FY2005 · ES
A Novel DNA Re-replication Checkpoint$329,831
R01 · FY2004 · ES
A Novel Carcinogen-Induced Cell Cycle Checkpoint$323,000
R01 · FY2004 · ES
A Novel Carcinogen-Induced Cell Cycle Checkpoint$326,000
R01 · FY2003 · ES
A Novel Carcinogen-Induced Cell Cycle Checkpoint$326,000
R01 · FY2002 · ES
NOVEL CARCINOGEN INDUCED CELL CYCLE CHECKPOINT$110,514
R29 · FY2001 · ES
NOVEL CARCINOGEN INDUCED CELL CYCLE CHECKPOINT$110,514
R29 · FY2000 · ES